Latest News

Researchers uncover a potential association between an APOE genetic variant and changes in brain metabolism leading to increased risk of Alzheimer’s disease and cognitive impairment.

Age-related macular degeneration is thought to begin with a combination of genetic and environmental risk factors that damage retinal cells and lead to the formation of small droplets that may be precursors to drusen. In early studies drugs that inhibit cholesterol help prevent this.

Learn about a key lifestyle change that could help decrease your risk for developing the devastating eye disease

BrightFocus funds investigator-initiated research around the globe on a wide range of approaches to understanding and intervening with the biological mechanisms of dementia. The foundation has a strong record of support for innovative research ideas from scientists in the early stages of their careers.

Learn how monocytes have shown a reduced ability to ingest waste particles, and glatiramer acetate, a drug approved to treat multiple sclerosis, showed promise in treating AMD.

WHAM, BrightFocus Foundation Join Together to Promote Increased Funding for Women-Focused Alzheimer’s Research.